MAPT and Alzheimer disease: Oxidative stress is involved in AD by promoting tau hyperphosphorylation, amyloid-β (Aβ) deposition, and synapse and neuron loss.4 In view of this, targeting oxidative stress has therapeutic potential in the prevention and management of AD.